E7-15831. Listing of Color Additives Subject to Certification; D&C Black No. 3; Confirmation of Effective Date  

  • Start Preamble

    AGENCY:

    Food and Drug Administration, HHS.

    ACTION:

    Final rule; confirmation of effective date.

    SUMMARY:

    The Food and Drug Administration (FDA) is confirming the effective date of July 20, 2007, for the final rule that appeared in the Federal Register of June 19, 2007 (72 FR 33664). The final rule amended the color Start Printed Page 45329additive regulations to provide for the safe use of D&C Black No. 3 (bone black, subject to FDA batch certification) as a color additive in the following cosmetics: Eyeliner, eye shadow, mascara, and face powder.

    DATES:

    Effective date confirmed: July 20, 2007.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Judith Kidwell, Center for Food Safety and Applied Nutrition (HFS-265), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740-3835, 301-436-1071.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In the Federal Register of June 19, 2007 (72 FR 33664), FDA amended the color additive regulations to add § 74.2053 (21 CFR 74.2053) to provide for the safe use of D&C Black No. 3 as a color additive in the following cosmetics: Eyeliner, eye shadow, mascara, and face powder.

    FDA gave interested persons until July 19, 2007, to file objections or requests for a hearing. The agency received no objections or requests for a hearing on the final rule. Therefore, FDA finds that the effective date of the final rule that published in the Federal Register of June 19, 2007, should be confirmed.

    Start List of Subjects

    List of Subjects in 21 CFR Part 74

    • Color additives
    • Cosmetics
    • Drugs
    End List of Subjects

    Therefore, under the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 321, 341, 342, 343, 348, 351, 352, 355, 361, 362, 371, 379e) and under authority delegated to the Commissioner of Food and Drugs (1410.10 of the FDA Staff Manual Guide), notice is given that no objections or requests for a hearing were filed in response to the June 19, 2007, final rule. Accordingly, the amendments issued thereby became effective July 20, 2007.

    Start Signature

    Dated: August 7, 2007.

    Jeffrey Shuren,

    Assistant Commissioner for Policy.

    End Signature End Supplemental Information

    [FR Doc. E7-15831 Filed 8-13-07; 8:45 am]

    BILLING CODE 4160-01-S

Document Information

Effective Date:
7/20/2007
Published:
08/14/2007
Department:
Food and Drug Administration
Entry Type:
Rule
Action:
Final rule; confirmation of effective date.
Document Number:
E7-15831
Dates:
Effective date confirmed: July 20, 2007.
Pages:
45328-45329 (2 pages)
Docket Numbers:
Docket No. 1995C-0286
PDF File:
e7-15831.pdf
CFR: (1)
21 CFR 74